Metastatic lymph node group:None

2 trials

Sponsors

Shanghai Chest Hospital, Henan Provincial People's Hospita,medical

Conditions

EGFR/ALK negative stage II-III non-small cell lung cancerNon-small cell lung cancer

Unknown Phase

The study on predicting the efficacy of neoadjuvant immunotherapy for resectable stage II-III non-small cell lung cancer based on PD-L1 spatial heterogeneity

RecruitingChiCTR2500107038

Shanghai Chest HospitalNon-small cell lung cancer

Start: 2025-08-10Updated: 2025-09-08

A Study on Predicting the Efficacy of Neoadjuvant Immunotherapy for Stage II-III Resectable Non-Small Cell Lung Cancer Based on Spatial Heterogeneity of PD-L1 Expression

RecruitingChiCTR2600118367

Henan Provincial People's Hospita,medicalEGFR/ALK negative stage II-III non-small cell lung cancer

Start: 2025-07-10Updated: 2026-02-09